Full course description
This course has been moved to a new learning platform in order to provide you with an even better online learning experience! Register in the new version of this course >>
Already enrolled or want to download your certificate? Access your Canvas dashboard directly here until June 30, 2022.
About this course
Precision Medicine for Your Practice is a series of short (30 min), online modules covering specific topics in genomics and precision medicine. In this module, Genomic Testing for the Healthy Individual, providers will learn how to assess the significance of results from different kinds of consumer genomic tests, recognize if, and in what way, these results may be medically actionable, and communicate with patients about their motivations and concerns. There are five parts of the module: overview via an animated video; practice cases to facilitate learning-by-doing; "dig deeper" for more in-depth topics; and logistics and additional resources for more detail.
Already enrolled? Access the course here.
Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual (CNE)
Original Publication Date: January 19, 2018
Renewal Date: September 21, 2020
Expiration Date: September 14, 2022
Upon completion of this educational activity, the learner will be able to:
- Facilitate patient knowledge of a wide range of genomic tests to support understanding of implications
This activity is designed to meet the educational needs of practicing nurses, advanced practice nurses, physicians and physician assistants who provide primary care.
CNE Approval Statement
The Jackson Laboratory is co-providing this continuing nursing education activity with the American Medical Association and Scripps Health. This continuing nursing professional development activity was approved by the Northeast Multistate Division (NE-MSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Claiming Your Credit
In order to claim credit 1) answer the pre-assessment questions, 2) work through the module content in its entirety, 3) successfully complete the post-assessment answering 4 out of 5 questions correctly and 4) complete the evaluation.
Nurses are eligible for a maximum of .50 contact hours upon the completion of this activity.
- Linda Steinmark, MS, CGC, Project Manager, Clinical and Continuing Education, The Jackson Laboratory
- Emily Edelman, MS, CGC, Associate Director, Clinical and Continuing Education, The Jackson Laboratory
- Kate Reed, MPH, ScM, CGC, Director, Clinical and Continuing Education, The Jackson Laboratory
- Therese Ingram Nissen, MA, Senior Instructional Designer/Technologist, The Jackson Laboratory
- Sean C. McConnell, PhD, Senior Policy Analyst, Health & Science, American Medical Association
- Laura Nicholson, MD, PhD, Director of Research, Graduate Medical Education (GME), Scripps Health
- Janet K. Williams, PhD, RN, FAAN, Professor of Nursing, Chair of Behavioral and Social Science Research, University of Iowa
Faculty and Authors
- Linda Steinmark, MS, CGC, Project Manager, Clinical and Continuing Education, The Jackson Laboratory (Author)
- Emily Edelman, MS, CGC, Associate Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
- Therese Ingram, MA, Senior Instructional Designer/Technologist, The Jackson Laboratory (Author)
- Kate Reed, MPH, ScM, CGC, Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
- Sean McConnell, PhD, Senior Policy Analyst, Health and Science, American Medical Association
- Laura Nicholson, MD, PhD, Director of Research, Graduate Medical Education (GME), Scripps Health (Author)
Subject Matter Experts
- Sawona Biswas, MS, CGC, Genetic Counselor, University of California, San Francisco (Content Expert)
- Howard Levy, MD, PhD, Associate Professor of Medicine, Johns Hopkins University (Content Expert)
- Emily Qian, MS, CGC Genetic Counselor, Yale University (Content Expert)
Conflict of Interest Disclosure
Unless otherwise noted, the program planners and faculty do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this course.
The following disclosures are reported that could be perceived as a real or apparent conflict of interest in the education program:
Janet K. Williams, PhD, RN, FAAN, stockholder of Pfizer. In her role as a planner, Dr. Williams recused herself from all deliberations relating to content related to the commercial entities with which she has a financial interest and is not responsible for reviewing for bias any related content. All educational material has been peer-reviewed by external reviewers to assess for bias.
Abul-Husn NS, Kenny EE. Personalized Medicine and the Power of Electronic Health Records. Cell. 2019; 177(1):58-69.
The All of Us Research Program Investigators. The “All of Us” Research Program. N Engl J Med. 2019; 381(7):668-676.
American College of Medical Genetics and Genomics. Clinical utility of genetic and genomic services: a position statement. Genet Med. 2015; 17(6):505-507.
American College of Medical Genetics and Genomics. Direct-to-consumer genetic testing: a revised position statement. Genet Med. 2015; 18(2):207-208.
American College of Medical Genetics and Genomics. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement. Genet Med. 2016; 19(2):249-255.
American College of Medical Genetics and Genomics Board of Directors. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019; 21(7):1467-1468.
Bunnik EM, Janssens ACJW, Schermer MHN. Personal utility in genomic testing: is there such a thing? J Med Ethics. 2015; 41(4):322-326.
Carey DJ, Fetterolf SN, Davis FD, et al. The Geisinger MyCode community health initiative: an electronic health record–linked biobank for precision medicine research. Genet Med. 2016; 18(9):906-913.
Hackmann M, Addie S, Alper J, Beachy SH. Exploring the Current Landscape of Consumer Genomics. Washington, D.C.. National Academies Press. 2020.
Kirkpatrick BE, Rashkin MD. Ancestry Testing and the Practice of Genetic Counseling. J Genet Counsel. 2016; 26(1):6-20.
Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020; 12(1).
Linderman M, Nielsen D, Green R. Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium. J Person Med. 2016; 6(2):14-29.
Lindor NM, Thibodeau SN, Burke W. Whole-Genome Sequencing in Healthy People. Mayo Clin Proc. 2017; 92(1):159-172.
Lu JT, Ferber M, Hagenkord J et al. Evaluation for genetic disorders in the absence of a clinical indication for testing: elective genomic testing. J Mol Diagn. 2019; 21(1), pp.3-12.
Lupo PJ, Robinson JO, Diamond PM et al. Patients’ perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. Pers Med. 2016; 13(1):13-20.
Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019; 104(1):21-34.
National Comprehensive Cancer Network Guidelines. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 1.2021. 11/2/2020.
National Comprehensive Cancer Network Guidelines. Genetic/Familial High-Risk Assessment: Colorectal. Version 1.2020. 11/2/2020.
Ostergren JE, Gornick MC, Carere DA et al. How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study. Public Health Genomics. 2015; 18(4):216-224.
Savard J, Hickerton C, Metcalfe SA, Gaff C, Middleton A, Newson AJ. From Expectations to Experiences: Consumer Autonomy and Choice in Personal Genomic Testing. AJOB Empirical Bioethics. 2019; 11(1):63-76.
Sirugo G, Williams SM, Tishkoff SA. The Missing Diversity in Human Genetic Studies. Cell. 2019; 177(1):26-31.
Tandy-Connor S, Guiltinan J, Krempely K, et al. False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care. Genet Med. 2018; 20(12):1515-1521.
Topol E. Individualized Medicine from Pre-womb to Tomb. Cell. 2014; 157(1):241-253.
Vassy JL, Christensen KD, Schonman EF et al. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients. Ann Intern Med. 2017; 167(3):159-70.
Vassy JL, Davis JK, Kirby C, et al. How Primary Care Providers Talk to Patients about Genome Sequencing Results: Risk, Rationale, and Recommendation. J Gen Intern Med. 2018; 33(6):877-885.
Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R. Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry. 2018; 8(1).
Wasson K, Sanders TN, Hogan NS, Cherny S, Helzlsouer KJ. Primary care patients’ views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study. J Community Genet. 2013; 4(4):495-505.
Audio speakers or headphones
Screen resolution of 800X600 or higher
Adobe Reader 5.0 or higher
For best performance in a mobile environment, please download the Canvas Mobile App for IOS and Android.
Should you have technical questions or questions regarding the content of the activity, please email Clinical and Continuing Education at the Jackson Laboratory.
All information in Precision Medicine for Your Practice is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Precision Medicine for Your Practice. Reliance on any information in Precision Medicine for Your Practice is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Precision Medicine for Your Practice.